Johnson & Johnson Newsroom

McDonald's To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday

Benzinga59minutes ago

Why Johnson & Johnson (JNJ) Surged on Monday

Yahoo Finance59minutes ago

Johnson & Johnson Analyst Ratings

Benzinga19:14 · Ratings

Jim Cramer Says You Should Buy Johnson & Johnson (JNJ) Dividend Stock With 3.3% Yield

Yahoo Finance19:12

Barclays Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166

Futu News17:31 · Ratings

Barclays Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $166

Futu News05:31 · Ratings

Unusual Options Activity: JNJ, TSM and Others Attract Market Bets, JNJ V/OI Ratio Reaches 384.6

EST Jan 27th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options

Futu News05:30

J&J Talc Claimants Urge Judge to Reject $8B Settlement, Bankruptcy Plan

Seeking Alpha04:28

Express News | J&J-Backed Medtech Firm Histosonics Considers US IPO; Histosonics May Seek a Valuation of Several Billion Dollars - Bloomberg News

Breakings04:12

10 Health Care Stocks With Whale Alerts In Today's Session

Benzinga01:35

Salesforce, Johnson & Johnson Share Gains Contribute To Dow's Nearly 150-Point Jump

MarketWatch01:28

Barclays Adjusts Johnson & Johnson's Price Target to $166 From $159, Keeps Equalweight Rating

MT Newswires01:26 · Ratings

FDA Accepts Teva, Alvotech BLAs for Simponi Biosimilars

Seeking AlphaJan 27 23:59

After the Bank of Japan rarely indicated an interest rate hike, the market may return to uncertainty.

To avoid being led by the market and given the uncertainty in the economic outlook, the Bank of Japan may restore ambiguous policy guidance.

Golden10 DataJan 27 14:05

Over 80% Companies Deliver EPS Wins This Week-Earnings Scorecard

Seeking AlphaJan 26 02:46

Argus Research Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $185

Futu NewsJan 24 21:31 · Ratings

Argus Research Sticks to Their Buy Rating for Johnson & Johnson (JNJ)

TipRanksJan 24 21:08

Is Johnson & Johnson (JNJ) the Best Diversified Dividend Stock to Buy Now?

Yahoo FinanceJan 24 20:14

Daiwa Adjusts Price Target on Johnson & Johnson to $150 From $170, Maintains Neutral Rating

MT NewswiresJan 24 19:05 · Ratings

Express News | Bio-Thera Solutions: The marketing authorization application for BAT2506 (Golimumab) injection has been accepted by the European EMA.

BreakingsJan 24 16:27